DE69918145D1 - Verwendung von diltiazem zur behandlung von pathologien der netzhaut - Google Patents
Verwendung von diltiazem zur behandlung von pathologien der netzhautInfo
- Publication number
- DE69918145D1 DE69918145D1 DE69918145T DE69918145T DE69918145D1 DE 69918145 D1 DE69918145 D1 DE 69918145D1 DE 69918145 T DE69918145 T DE 69918145T DE 69918145 T DE69918145 T DE 69918145T DE 69918145 D1 DE69918145 D1 DE 69918145D1
- Authority
- DE
- Germany
- Prior art keywords
- diltiazem
- retal
- treatment
- skin pathologies
- pathologies
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
- Prostheses (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9812364 | 1998-10-02 | ||
FR9812364A FR2784030B1 (fr) | 1998-10-02 | 1998-10-02 | Utilisation de bloqueurs des canaux calciques et/ou cgmp-dependants pour le traitement de pathologies de la retine |
PCT/FR1999/002346 WO2000020006A1 (fr) | 1998-10-02 | 1999-10-01 | Utilisation du diltiazem pour le traitement de pathologies de la retine |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69918145D1 true DE69918145D1 (de) | 2004-07-22 |
DE69918145T2 DE69918145T2 (de) | 2005-08-11 |
Family
ID=9531128
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69918145T Expired - Fee Related DE69918145T2 (de) | 1998-10-02 | 1999-10-01 | Verwendung von diltiazem zur behandlung von pathologien der netzhaut |
Country Status (9)
Country | Link |
---|---|
US (1) | US6716835B1 (de) |
EP (1) | EP1117408B9 (de) |
JP (1) | JP2002526411A (de) |
AT (1) | ATE269085T1 (de) |
AU (1) | AU5870099A (de) |
DE (1) | DE69918145T2 (de) |
ES (1) | ES2219060T3 (de) |
FR (1) | FR2784030B1 (de) |
WO (1) | WO2000020006A1 (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2823221B1 (fr) | 2001-04-06 | 2004-04-02 | Univ Pasteur | Sequences associees a la degenerescence retinienne et applications |
US7445777B2 (en) | 2002-10-01 | 2008-11-04 | Paola Ammannati | Enzymatic treatment of retinitis pigmentosis |
CA2995880C (en) | 2009-01-16 | 2021-01-05 | Exelixis, Inc. | Processes for preparing n-(4-{[6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide |
US20110021974A1 (en) * | 2010-10-05 | 2011-01-27 | Shantha Totada R | Retinitis pigmentosa treatment and prophalaxis |
CN103748154B (zh) | 2011-07-15 | 2015-11-25 | 索尔维特殊聚合物意大利有限公司 | 用于多层组件的氟聚合物组合物 |
ES2689136T3 (es) | 2013-07-31 | 2018-11-08 | Novartis Ag | Nuevos vectores de selección y métodos de selección de células hospedadoras eucariotas |
JP6954582B2 (ja) * | 2016-12-22 | 2021-10-27 | 国立大学法人滋賀医科大学 | 医薬組成物 |
FR3081325B1 (fr) | 2018-05-23 | 2020-10-09 | Univ Claude Bernard Lyon | Diltiazem pour son utilisation dans le traitement des infections microbiennes |
WO2020123312A1 (en) * | 2018-12-09 | 2020-06-18 | Weinberg Assa | Method to prevent and treat macular degeneration by vasodilators |
FR3106055B1 (fr) | 2020-01-13 | 2022-01-28 | Centre Nat Rech Scient | Combinaison de diltiazem et autres agents antiviraux |
FR3108033B1 (fr) | 2020-03-10 | 2023-04-21 | Univ Claude Bernard Lyon | COMPOSES ANTIVIRAUX ET LEURS COMBINAISONS POUR TRAITER L’INFECTION VIRALE PAR LE SARS-CoV-2 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990006118A1 (en) * | 1988-12-05 | 1990-06-14 | Houston Biotechnology Incorporated | Therapeutic use of dihydropyrimidones and benzazepine and benzothiazepine derivatives in retinal or optic nerve dysfunction |
US5597809A (en) * | 1994-06-23 | 1997-01-28 | Massachusetts Eye & Ear Infirmary | Treatment of optic neuritis |
US5431907A (en) * | 1994-08-03 | 1995-07-11 | Abelson; Mark B. | Treatment of vascular disorders of the posterior segment of the eye by topical administration of calcium channel blocking agents |
DE19718826A1 (de) * | 1997-05-05 | 1998-11-12 | Marion S Dr Eckmiller | Verwendung biologisch aktiver Wirkstoffe zum Beeinflussen des Extrazellulär-Raumes von Sinneszellen und Verfahren zur Wirkstoff-Administrationssteuerung |
-
1998
- 1998-10-02 FR FR9812364A patent/FR2784030B1/fr not_active Expired - Fee Related
-
1999
- 1999-10-01 AU AU58700/99A patent/AU5870099A/en not_active Abandoned
- 1999-10-01 AT AT99946279T patent/ATE269085T1/de not_active IP Right Cessation
- 1999-10-01 US US09/806,577 patent/US6716835B1/en not_active Expired - Fee Related
- 1999-10-01 ES ES99946279T patent/ES2219060T3/es not_active Expired - Lifetime
- 1999-10-01 WO PCT/FR1999/002346 patent/WO2000020006A1/fr active IP Right Grant
- 1999-10-01 EP EP99946279A patent/EP1117408B9/de not_active Expired - Lifetime
- 1999-10-01 DE DE69918145T patent/DE69918145T2/de not_active Expired - Fee Related
- 1999-10-01 JP JP2000573365A patent/JP2002526411A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP1117408B1 (de) | 2004-06-16 |
US6716835B1 (en) | 2004-04-06 |
AU5870099A (en) | 2000-04-26 |
JP2002526411A (ja) | 2002-08-20 |
EP1117408A1 (de) | 2001-07-25 |
ATE269085T1 (de) | 2004-07-15 |
EP1117408B9 (de) | 2004-11-10 |
DE69918145T2 (de) | 2005-08-11 |
ES2219060T3 (es) | 2004-11-16 |
FR2784030A1 (fr) | 2000-04-07 |
FR2784030B1 (fr) | 2002-12-20 |
WO2000020006A1 (fr) | 2000-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1021179A4 (de) | Verfahren zur förderung des haarwuchses und entwicklung des haarsystems | |
DE69921156D1 (de) | Verwendung von 5ht-6 antagonisten zur behandlung adhd | |
ATE389411T1 (de) | Strontium verbindung zur behandlung von sub- dermalem weichteilschmerz | |
DE60118544D1 (de) | Methoden und zusammensetzungen zur modulation der aktivität der alpha-adrenergen rezeptoren | |
DE60137430D1 (de) | Gewebeimplant zur wiederherstellung von knorpelgewebe | |
DE69838338D1 (de) | Verwendung von antimykotica zur topischen behandlung von pilz-induzierten schleimhautentzündungen | |
DE69836640D1 (de) | Vorrichtung zur behandlung von gewebe mit mehrfach-elektroden | |
ATE271038T1 (de) | 4-phenylpiperidine zur behandlung von prutitischen hauterkrankungen | |
DE60108857D1 (de) | Methoden und zusammensetzungen zur modulierung der aktivität von alpha-adrenergen rezeptoren | |
ATE555803T1 (de) | Verwendung von osteopontin zur behandlung und/oder vorbeugung von neurologischen erkrankungen | |
DE69918145D1 (de) | Verwendung von diltiazem zur behandlung von pathologien der netzhaut | |
DE69938179D1 (de) | Kombination von riluzol und levodopa zur behandlung von morbus parkinson | |
DE69638281D1 (de) | Anti-Interleukin-9 Antikörper oder Anti-Interleukin-9 Rezeptor Antikörper zur Behandlung von bronchialem Hyperreaktionsvermögen | |
ATE326534T1 (de) | Methode zur behandlung von muskelkrankheiten | |
DE60213116D1 (de) | Verwendung von carbinolen zur behandlung von neuropathischer funktionsstörung | |
DE69924284D1 (de) | Verwendung von stimulatoren der neurotrophischen faktoren zur behandlung von neurodegenerativen ophthalmischen krankheiten | |
ATE261724T1 (de) | Antikonvulsive derivate zur behandlung von posttraumatischen stresserkrankungen | |
NO984189L (no) | FremgangsmÕte for behandling av bipolar forstyrrelse | |
DE69734349D1 (de) | Behandlung von knochenleiden mit adrenomedullin | |
ATE291434T1 (de) | Verwendung von angiotensin zur behandlung von krebsmetastasierung | |
DE69926996D1 (de) | Verwendung von riluzol zur behandlung der retinalischemie | |
ATE275949T1 (de) | Verwendung von diminazen-di-aceturat und/oder pentamidin zur behandlung von malaria | |
FR2816633B1 (fr) | Methode de criblage d'agents susceptibles de traiter l'obesite | |
DE69619542D1 (de) | Bismut enthaltende zusammensetzungen zur verhütung und behandlung gastrointestinaler beschwerden | |
ATE299021T1 (de) | Verwendung von oxazolidinonderivaten zur behandlung von psoriasis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE M |
|
8339 | Ceased/non-payment of the annual fee |